Gastric microbiome-derived Lacticaseibacillus casei strain RIGLD MG-1 relieves Helicobacter pylori-induced inflammation in gastric epithelial cells in vitro - Ghasemipoor, Masoomeh; Yaghoubi-Avini, Mohammad; Azimirad, Masoumeh; Nabavi-Rad, Ali; Looha, Mehdi Azizmohammad; Doulberis, Michael; Schulz, Christian; Yadegar, Abbas (Molecular biology reports, 2025)
Keywords: Adult; Animal Anatomy; Animal Biochemistry; Anti-inflammatory agents; Antibiotic resistance; Antibiotics; Bacteria; Biomedical and Life Sciences; Biopsy; Cancer; Cell Line; Cell viability; Chronic illnesses; Endoscopy; Enzyme-linked immunosorbent assay; Epithelial cells; Epithelial Cells - metabolism; Epithelial Cells - microbiology; Female; Gastric Mucosa - metabolism; Gastric Mucosa - microbiology; Gastroenterology; Gastrointestinal Microbiome; Helicobacter Infections - microbiology; Helicobacter Infections - therapy; Helicobacter pylori; Helicobacter pylori - drug effects; Helicobacter pylori - pathogenicity; Histology; Humans; Immunomodulation; Infections; Inflammation; Inflammation - microbiology; Interleukin 10; Interleukin 8; Lacticaseibacillus casei; Lacticaseibacillus casei - isolation & purification; Lacticaseibacillus casei - metabolism; Lacticaseibacillus casei - physiology; Lactobacillus; Life Sciences; Liver diseases; Male; Microbiomes; Microorganisms; Middle Aged; Morphology; NF-κB protein; Original Article; Probiotics; Probiotics - pharmacology; Substance abuse treatment; Tumor necrosis factor-TNF; Tumor necrosis factor-α; β-Catenin; Iran; United States--US; Germany; Probiotic; AGS cells; Inflammation; Gastric Microbiome; Helicobacter pylori; Lacticaseibacillus casei